Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale
✍ Scribed by Ardan M. Saguner; Andreas Wahl; Fabien Praz; Stefano F. de Marchi; Heinrich P. Mattle; Stéphane Cook; Stephan Windecker; Bernhard Meier
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 201 KB
- Volume
- 77
- Category
- Article
- ISSN
- 1522-1946
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background: Percutaneous closure of patent foramen ovale (PFO) is routinely performed with nonbiological devices, characterized by a persistent low‐grade inflammatory response. We report our experience about PFO closure with a bioabsorbable device, BioSTAR® (NMT Inc, USA). ## Metho
## Abstract Closure of patent foramen ovale (PFO) has been proposed as an alternative to anticoagulation in patients with presumed paradoxical emboli. We report the immediate and mid‐term results of the phase 1 U.S. Multicenter Clinical Trial of patients who underwent transcatheter PFO closure for